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Nerve conduction velocity in patients 
under long term treatment with antiepileptic drugs 
K . - H . Krause and P. Beritt1 
Abstract 
Motor and sensory nerve conduction velocity (NCV) of median nerve and motor NCV of peroneal 
nerve were measured in 548 epileptic patients, aged 20 to 40 years, under long term treatment with 
antiepileptic drugs. Compared with a control collective of 70 healthy persons in the same age the 
epileptics showed a reduction of all NC Vs. 19 percent of the epileptic collective had at least 1 
diminished NCV. Negative correlations with total amount and average daily dose of antiepileptic drugs 
were found in both sexes for sensory NCV of median nerve and motor NCV of peroneal nerve, only in 
males also for motor NCV of median nerve. 
Only in females, duration of therapy correlated negative with sensory NCV of median and motor 
NCV of peroneal nerve. In patients under monotherapy the group with carbamazepine treatment showed 
the lowest NCV values, the difference being significant for motor NCV of median nerve in comparison 
to phenytoin and valproate sodium. It is concluded, that NCV generally is lowered under long term 
treatment with antiepileptic drugs and that phenytoin has no specific influence compared with the other 
drugs. 
Introduction 
A negative influence of phenytoin on the 
function of peripheral nerves has been dis-
cussed already in 1942 (10). Meanwhile a rever-
sible lowering of nerve conduction velocity 
(NCV) has been prooven in cases with acute 
phenytoin intoxication (1, 13, 18, 21). Concern-
ing the possible implication of long term treat-
ment the discussion is controverse: studies 
showed different results, the frequency of elec-
trophysiological abnormalities ranging from 
0% to 89% (2, 5-9, 11, 16, 22, 24-26). Ramirez 
et al. described a reversible neuropathy after 30 
years of phenytoin administration, character-
ized by axonal shrinkage and secondary demye-
lination in sural nerve biopsy (19). The aim of 
our study was: 1. to compare NCV's of a big 
number of patients, treated for a long time with 
Department of Neurology. University of Heidelberg, F.R.G. 
several antiepileptic drugs, with those of a 
control collective, 2. to evaluate possible rela-
tions of NCV's with total amount and daily 
dose of anticonvulsants as well as with the 
duration of treatment, and 3. to compare the 
patients under monotherapy with respect to 
possible differences in NCV's. 
Materials and methods 
548 epileptics (313 males, 235 females) of 
the Heidelberg outpatient clinic for convulsive 
disorders were investigated, who took antiepi-
leptic drugs since 1 year at least. To keep out 
influences of age, well-known for NCV's, only 
patients with an age of 20 to 40 years were 
considered. A further criterion for exclusion 
was the presence of a possible other cause of 
for neuropathy like diabetes mellitus, uremia or 
alcohol abuse. For each anticonvulsant drug 
taken by the patient, duration of therapy and 
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average daily dose were fixed. The whole dose 
and the average daily dose of all anticonvul-
sants were expressed as equivalent units, 1 unit 
equalling 50 mg phenytoin, 30 mg phenobarbi-
tal, 125 mg primidone, 50 mg CHP-phenobarbi-
tal, 200 mg carbamazepine, 50 mg mepheny-
toin, 250 mg ethosuximide, 300 mg valproate 
sodium, 2 mg clonazepam, 300 mg mesuximide, 
100 mg sultiam, or 250 mg trimethadione. 
NCV's were compared by Wilcoxon test with 
the values of 70 healthy controls of the same 
age group. Motor conduction velocity (MCV) 
of median and peroneal nerve was measured 
with a DISA 1500 E M G system using surface 
stimulating and recording electrodes, sensory 
conduction velocity (SCV) of median nerve on 
the forearm in antidromic technique using ring 
electrodes on the second digit. Skin temperature 
was constant at 34 °C by use of an automatic 
DISA skin temperature system. 
Results 
The epileptics had lower mean values of 
NCV's compared with the controls (table 1). 69 
epileptics showed a slowering of M C V of 
peroneal nerve <45 m/s, 21 a reduction of 
M C V of median nerve <50 m/s and 44 a 
reduction of SCV of median nerve <55 m/s 
(see Figures 1-3). Considering overlapping in 
some patients, 102 epileptics remained with at 
least 1 pathological value of NCV. Correlation 
with drug parameters were calculated sepa-
rately for males and females, because both 
sexes differed in dose of medication (Krause, 
1987). In both sexes, M C V of peroneal nerve 
and SCV of median nerve correlated negative 
with drug parameters, whereas only in males 
M C V of median nerve showed such a correla-
tion (Table 2). The results of the patients under 
monotherapy with phenytoin, carbamazepine, 
primidone, or valproate sodium since 1 year at 
least are compiled in Table 3. For all NCV's 
the group under carbamazepine showed the 
lowest values, this difference being significant 
for M C V of median nerve in Kruskal-Wallis 
test (/7<0.05) and after Duncan (for carbama-









45 "So" 55 60 65 m/s 
Fig. 1. Frequency distribution of motor conduction 
velocity of median nerve in the forearm in epileptics ( I ) 







50 55 60 65 70 75 m/s 
Fig. 2. Frequency distribution of sensory conduction 
velocity of median nerve in the forearm in epileptics (1) 








40 45 50 55 60 m/s 
Fig. 3. Frequency distribution of motor conduction 
velocity of peroneal nerve in epileptics (1) and con-
trols (2). 
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Table 1. — Mean value and standard deviation of motor and 
sensory conduction velocity of median nerve and of motor 
conduction velocity of peroneal nerve in epileptics and 
controls with p value of Wilcoxon test 
Epilept: ics Controls 
P 
n X SD n X SD 
Median nerve, MCV 548 55.8 4.0 70 57.5 3.3 0.0002 
Median nerve, SCV 548 61.1 4.8 70 62.7 3.9 0.0014 
Peroneal nerve, MCV 548 49.3 3.9 70 51.9 4.0 0.0001 
Table 2. — Correlations between drug parameters (total 
amount of all anticonvulsants as equivalent units, average 
daily dose as equivalent units per day and duration of 
ant (epileptic treatment) and motor and sensory conduction 
velocity of median as well as motor conduction velocity of 
peroneal nerve (R = Spearman 'rank correlation coefficient 
and p value) in epileptic males (m, n = 313) and females (f 





Median nerve, m R= -0.13254 R= -0.13747 n.s. 
MCV /> = 0.0190 p = 0.0149 
f n.s. n.s. n.s. 
Median nerve, m R=-0.14491 R=-0.19165 n.s. 
SCV p = 0.0103 p = 0.0007 
f R=-0.17483 R= -0.13712 R= -0.15571 
p = 0.0072 p = 0.0357 /; = 0.0169 
Peroneal nerve, m R=-0.13731 R=-0.14558 n.s. 
MCV /? = 0.0151 y7 = 0.0099 
f R =-0.19850 R= -0.14275 R= - 0.19896 
p = 0.0022 p = 0.0287 p = 0.0022 
Table 3. — Mean value and standard deviation of motor and 
sensory conduction velocity of median nerve and motor 
conduction velocity of peroneal nerve in epileptics under 
monotherapy with phenytoin (PHT), primidone (PRM), 
carbamazepine (CBZ) or valproate sodium (VPA) 
PHT PRM 
n = 53 n = 81 
CBZ VPA 
n = 53 n = 32 
Median nerve, 
MCV 57.5±4.2 56.1 ±4 .2 54.9±4.3 56.7±3.9 
Median nerve, 
SCV 62.7±4.5 62.2±4.4 60.7±6.0 61.9±4.7 
Peroneal nerve, 
MCV 50.0±3.8 50.0±3.9 49.3±4.5 49.5±3.5 
Discussion 
The results of our study indicate, that long 
term therapy with antiepileptic drugs causes a 
lowering of NCV's. The influence of medication 
is confirmed by the negative correlations found 
between NCV's and mean daily dose a well as 
total amount of anticonvulsants taken by the 
epileptics. In accordance with the results of 
Geraldini et al. (12) and Taylor et al. (23) the 
males showed no correlations with duration of 
therapy, whereas the females of our study did 
so. The correlations between medication and 
M C V of peroneal nerve were more pronounced 
than those with NCV's of median nerve; so, the 
M C V of peroneal nerve seems to be the most 
sensitive in our study. The frequency of 19% of 
patients with at least one diminished NCV is in 
accordance with the incidence described by 
Lovelace and Horwitz (16) and Swift et al. (22). 
Swift et al. also found lowering of M C V of 
peroneal nerve as the most frequent sign of 
nerve involvement (22). As own investigations 
have shown, most cases with slowering of 
NCV's are only subclinical neuropathies with 
neither subjective complaints nor pathological 
reflex status (15). Concerning type of drugs, in 
former studies especially phenytoin has been 
thought to cause lowering of NCV's ("hydan-
toin neuropathy"); but patients with chronic 
intake of antiepileptic drugs mostly have a 
combination therapy with at least 2 drugs (20). 
The influence of the other anticonvulsants on 
NCV is not clear, regarding the literature: 
Results concerning the possible role of carba-
mazepine are controversial (3, 4, 17, 21, 22, 24, 
25); in patients under monotherapy with barbi-
turates an influence has been suggested, but 
only 6 patients were examined (21). Comparing 
the patients under monotherapy we found no 
significant differences in the M C V of peroneal 
nerve and SCV of median nerve; but M C V of 
median nerve was lower in the patients under 
carbamazepine compared to those under phe-
nytoin and valproate sodium. It is of interest, 
that Danner et al. in their prospective study 
also found lower NCV of median nerve under 
treatment with carbamazepine compared to 
phenytoin (3). A l l in all, the results of our study 
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suggest, that 1. under long term antiepileptic 
treatment mean NCV is lowered and that 2. 
phenytoin in long term therapy has no specific 
influence on NCV compared to other antiepi-
leptic drugs. This is also confirmed by the 
results of Geraldini et al. (12). Therefore we 
propose to change the term " hydantoin neuro-
pathy" into "anticonvulsant neuropathy" or 
"neuropathy induced by antiepileptic drugs". 
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